selegiline has been researched along with gsk2879552 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Duan, Y; Guan, Y; Liu, H; Qin, W; Suo, F; Wang, X; Zhai, X; Zheng, Y | 1 |
1 other study(ies) available for selegiline and gsk2879552
Article | Year |
---|---|
Design, synthesis and in vitro evaluation of stilbene derivatives as novel LSD1 inhibitors for AML therapy.
Topics: Antineoplastic Agents; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Design; Drug Screening Assays, Antitumor; Enzyme Inhibitors; Histone Demethylases; Humans; Leukemia, Myeloid, Acute; Molecular Docking Simulation; Molecular Structure; Stilbenes; Structure-Activity Relationship; THP-1 Cells | 2018 |